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In this study we isolate and identify the Enteropathogenic Escherichia coli (EPEC) causing diar-
rhea in children less than ﬁve years in Cairo, Egypt, during different seasons. Children younger
than ﬁve years with diarrhea, attending the Pediatric Gastroenterology Intensive Care Unit of the
Cairo University Pediatric Hospital in one year period were our group of study. Our control group
was age and sex matched concurrent healthy children. The identiﬁed E. coli isolates were sub-
jected to antimicrobial disc diffusion susceptibility test and further identiﬁed for EPEC serotype by
slide agglutination test, using antiserum E. coli somatic trivalent I (O111, O55, O26) according
to the instructions of the manufacturer. Out of 134 patients 5.2% of them revealed EPEC in the
fecal sample, while the 20 children control group showed no EPEC isolates in their samples. Our
EPEC frequency showed variations from the compared results of other studies. Higher rate of
EPEC (18.7%) was found in patients between 2 to 3 years, while EPEC rate was (7.5%) in pa-
tients less than 6 months old, with P < 0.05. EPEC was identiﬁed from fecal specimens as a
unique pathogen or associated with other pathogens in acute and chronic diarrhea in children.
EPEC were detected in all seasons except in winter, and was predominant in summer season.
Four (57%) EPEC isolates were resistant to ampicillin, ticarcillin, and cotrimoxazole, and (14.3%)
to the third generation cephalosporins.
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1. Introduction
The diarrheagenic E. coli pathotypes that cause diarrhea include enteropathogenic E. coli (EPEC), enter-
otoxigenic E. coli (ETEC), enteroinvasive E. coli (EIEC), Shiga toxin-producing E. coli (STEC), diﬀusely
adherent E. coli, and enteroaggregative E. coli. These pathotypes are deﬁned by the presence or absence
of one or more deﬁnable E. coli virulence factors [1]. Enteropathogenic E. coli (EPEC) strains are diar-
rheagenic E. coli, which usually are classiﬁed by a combination of oligosaccharides (O), ﬂagella (H), and
capsular(K)antigens.Theyareassociatedwithoutbreaksofinfantilediarrheaamongchildrenindeveloping
countries. In contrast to the limited importance of EPEC in industrialized countries, EPEC is a major cause
of diarrhea in developing countries. Studies in Brazil, Mexico, and South Africa have shown that 30–
40% of infant diarrhea can be accredited to EPEC. These strains are also an important cause of disease
in nosocomial outbreaks, outpatient clinics, patients referred to hospitals, and urban and rural areas [2].
It had been demonstrated that the incidence of community-acquired EPEC infection was highest in
the six-month period following childbirth and that the infection was more sever in younger children. In
developing countries, the situation was much diﬀerent; EPEC organisms were a major cause of endemic
infantile diarrhea, exacerbated by seasonal outbreaks. There are certain serotypes, which are much more
likely to be encountered in diarrhea than others.
Serotypes O55:H12/45, O86:H48, O127:H21, O142:H48, O126:H48, and O126:H19 were signif-
icantly associated with diarrhea in children [3]. Serotypes O55:H6 and O111:H2 [4], O111:H2 and
O111:H—were reported as most frequent isolates in diﬀerent geographical areas [5]. Fortunately, EPEC
diarrhea is usually self-limited and rehydration is the most eﬀective treatment. The use of antibiotics in
general is of minor importance and has been criticised on the grounds of drug toxicity and the risk of
increased wide-spread antimicrobial resistance [6, 7].
Although diarrheagenic E. coli pathotypes are of public health relevance, they are not routinely
sought as enteric pathogens in clinical laboratories worldwide; thus, their incidence in children less than 2
years of age and their importance in community-acquired diarrhea are generally unknown, particularly in
areas of endemicity [1].
In the present study, we isolated and identiﬁed the enteropathogens E. coli causing diarrhea among
children less than ﬁve years old in Cairo, Egypt, during the diﬀerent seasons, and study their patterns of
resistance to diﬀerent antimicrobial agents used for the treatment of patients with diarrhea.
2. Materials and Methods
2.1. Study Population
This cross-sectional study included infant and young children younger than ﬁve years with diarrhea,
attending the Pediatric Gastroenterology Intensive Care Unit of the Cairo University Pediatric Hospital
from January 2009 to December 2009. Information was also obtained from each patient regarding age, sex,
onset of diarrhea, antibiotic intake, other relevant clinical information, and laboratory results. Diarrhea was
deﬁned as three or more liquid or semiliquid stools defecation per day. Our exclusion criteria were age more
than 5 years, no diarrhea, incomplete data, and dry or suspected contaminated sample. Twenty age and sex
matched concurrent healthy children who had had no diarrheal complaints during the previous month and
were not on antibiotics for 1 week were included in this study as a control group.
Data collection was performed using references of other studies, for comparison between our results
and other results in Egypt and other countries.
2.1.1. Microbiological Study
Stoolspecimenswerecollectedfromthepatientsinclear,transparent,wide-mouthedbottlesandtransported
to the microbiology department of the laboratory. The specimens were examined for consistency, color,
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TABLE 1: Age and sex of 134 children with diarrhea and positive EPEC in different age groups.
Age/month Number of samples Females no. (%) Males no. (%) Total positive no. (%) P = 0.018
<6 53 23 (42) 30 (38) 4 (7.5)
7–12 40 18 (33) 22 (28) 0 (0.0)
13–24 25 9 (16) 16 (20) 0 (0.0)
25–60∗ 16 5 (9) 11 (14) 3 (18.7)
Total 134 55 (41) 79 (59) 7 (5.2)
∗2 EPEC isolated from 2-year-old boy and 1 from 3-year-old. P < 0.05.
and atypical components such as mucous, blood, and parasites, examined by light microscope for the
presence of red blood cells, pus cells, parasitic ova, and protozoa, inoculated onto Blood, MacConkey,
SalmonellaShigella(SS) agar media, and SeleniteF broth, and incubatedat 37◦C for 24h. The isolateswere
subjected to the following tests: Gram staining, citrate utilization, oxidase test, and subcultured on lysine
iron agar (LIA), motility indole ornithine (MIO), and triple sugar iron agar (TSI) (Oxoid LTD, Basingstoke,
Hampshire, England). All tests were done using the methods described by [8].
2.2. Serotyping
Three to ﬁve colonies of each sample isolates were identiﬁed by biochemical assay, and E. coli were
selected for subculture on blood agar medium for serogrouping. Determination of the EPEC serogroups
was performed by slide agglutination test using antiserum E. coli somatic trivalent I (O111, O55, O26)
according to the instructions of the manufacturer (BIO-RAD, Marnes-la-Coquette, France).
2.2.1. Antimicrobial Susceptibility Testing
Antimicrobial drug susceptibility testing was done using standard methods (disc diﬀusion method) using
Mueller-Hinton agar according to the guidelines of Clinical and Laboratory Standards Institute (CLSI,
2009) [9] using the following antibiotic discs: amikacin (30μg), amoxicillin-clavulanic acid (30μg),
ampicillin-sulbactam (20μg), ampicillin (10μg), aztreonam (30μg), ceftriaxone (30μg), cefepime (30μg),
cefoperazone (30μg), cefoxitin (30μg), ceftazidime (30μg), cephalexin (30μg), cotrimoxazole (25μg),
gentamicin (10μg), imipenem (10μg), and ticarcillin (75μg) (Mast group, Merseyside, U.K.).
2.3. Statistical Analysis
Statistical analysis was done with Excel add-in Megastat, version 10.1 software (2007) using Chi-squared
test. P values <0.05 were considered signiﬁcant.
3. Results and Discussion
A totalof 156 consecutivenonrepeatsamplesfrom childrenunder 5 years old with diarrhea were includedin
our study. Only appropriate samples from 134 patients with complete data were examined for the presence
of EPEC. Our control group revealed no EPEC or other enteric pathogens (P < 0.05). Males in this study
constituted 59% of the studied group with diarrhea, and females were 41%. All cases positive for EPEC
were males. The total percentages of E. coli isolates were 51.5% (69/134); of which, 46% (62) were E. coli
not EPEC, and 5.2% (7) were EPEC (Table 1).
Two cases with prolonged diarrhea had EPEC, and the other 5 cases with acute diarrhea had E.
histolytica in association with EPEC (of which one case only was feverish and revealed E. histolytica,
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TABLE 2: Clinical and laboratory data of cases with EPEC.
Sample no. Month Age Sex
Stool analysis
Culture result Antibiotic resistance
Consistency pus Protozoa




2 June 3y ♂ Loosed 0-1 Negative EPEC No resistance
3 June 2m ♂ Loosed 0-1 Negative EPEC A, TS, TC
4J u l y 5 m ♂ Loosed >100 E. histolytica
EPEC + Klebsiella
spp.
A, TS, TC, ATM,
CRO, CPM, CPZ
5J u l y 2 y ♂ Watery 0-1 E. histolytica EPEC + Proteus No resistance




7S e p . 3 m ♂ Loosed >50 E. histolytica EPEC A, TS, TC
∗Only this patient was not on antibiotic at time of sampling; other patients were on β-lactam antibiotics.
All cases have acute diarrhea except no. 2 and 3 which have prolonged diarrhea.
TC: ticarcillin; TS: cotrimoxazole; A: ampicillin; CPZ: cefoperazone; CPM: cefepime; CRO: ceftriaxone.
TABLE 3: Comparison between different previous studies and our study.
Place Year No. of cases No. of EPEC % of EPEC Reference
Iran 2009 111 50 44.9 [2]
Bangladesh 1983 104 24 23.1 [11]
Jordan 2000 265 34 12.8 [12]
Nigeria 2009 100 15 15 [3]
Egypt
Cairo 1982 266 21 8 [13]
Ismailia 1990 65 9 13.8 [14]
Assiut 1992 150 47 31.3 [15]
Tanta 1994 100 22 22 [16]
Cairo 2009 134 7 5.2 Our study
EPEC, and Salmonella spp.) (Table 2). Only one patient with EPEC was not on antibiotic therapy before
sample release, while the all other (6) patients were on antibiotic therapy (β-lactam).
Four (57%) isolates of EPEC were resistant to ampicillin, ticarcillin, and cotrimoxazole, 1 (14.3%)
to the third-generation cephalosporins, and no resistance (0%) were detected to imipenem, amikacin, and
gentamicin.
Estrada-Garciaetal.[1]demonstratedasigniﬁcantassociationofanenteropathogenicE.coli(EPEC)
with community-acquired acute diarrhea lasting 7 to 12 days among Mexican children, suggesting that
EPEC is more associated with protracted diarrhea than the other diarrheagenic E. coli pathotypes. In our
study, a total of 134 stool specimens were analyzed in this study; E. coli species were isolated at a rela-
tively high rate (51.5%) with 5.2% of samples positive for enteropathogenic E. coli.T h i si sl o w e rt h a nt h e
prevalence in other studies at Nigeria and Iran (15% and 44.9%, resp.) [3, 10]. Also, it was lower than the
prevalence documented in previous studies in Egypt (Table 3).
One probable reason for this diﬀerence between our study and other studies in Nigeria and Iran may
beduetothenumberofchildrenbeingexclusivelybreastfedinthosestudiesasinEgyptmostofthemothers
exclusively breast fed their children till the age of 1 to 2 years. Breast milk (colostrum) from mothers living
in endemic areas has been reported to contain high levels of immunoglobulin A (IgA) antibodies against the
EPEC virulence factors [10]. The reason for the diﬀerence between our study and previous studies in Egypt
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FIGURE 1: Percent of E. coli and EPEC in children with diarrhea/season.
could be due to increased awareness to clean food preparations and proper hand hygiene, as a result of
intensive education programs carried out by the ministry of health and the media after H5N1(Avian ﬂu) and
H1N1 (Swine ﬂu) outbreaks in 2006 and 2008, respectively. However, further studies could be indicated to
rule the eﬀect of the educationalprograms on reduction of the infectionscaused by diarrheagenic pathogens.
In this study, the highest rate of EPEC was found in children between 2 and 3 years (18.7%), followed by
childrenbelow6 monthsold(7.5%). OurstatisticalanalysissuggeststhatEPECwassigniﬁcantlyassociated
with diarrhea in children in this two age groups (P < 0.05). This trend agrees with several studies which
had shown that the peak of incidence of enteritis was always in the few months after the beginning of the
weaning period and most of EPEC infections occur in the ﬁrst 3 years of life [17]. However, in other studies,
they demonstrated that the incidence of community-acquired EPEC infection is highest in the six-month
period following childbirth and that the infection is more severe in younger children [18, 19].
In this study, non-EPEC E. coli species showed highest peak in summer followed by autumn. EPEC
isolates were detected in all seasons except winter, but they appeared as predominant in the summer season
(warm and dry season) (Figure 1).
This trend agrees with the ﬁndings in other studies [17, 20], which reported that EPEC infections
show a marked seasonality and are associated with warm season peaks and [21], reported that peak rates of
EPEC infection occurred mainly in the dry summer months. However, the diﬀerence was not found to be
statistically signiﬁcant.
Five patients with acute diarrhea revealed EPEC in association with other pathogens in their fecal
samples,whiletheothertwopatientswithprolongeddiarrhearevealedEPECasauniquepathogenicisolate,
which demonstrates the importance of EPEC as single pathogen of infection or associated in coinfection.
Six (85.7%) patients in the current study were on β-lactam antibiotic therapy before stool sampling;
of which, 57% of them revealed EPEC resistant to ampicillin, ticarcillin, and cotrimoxazole and 14.3% to
third-generation cephalosporins. The misuse of β-lactam antibiotic largely is because they are inexpensive
and can be obtained easily without a doctor’s prescription. Resistance is probably due to indiscriminate
antibiotic usage (drug abuse) which could result in plasmid-mediated antibiotic resistance found to be
common in E. coli [8].
High rate of resistance of EPEC was also recorded for ampicillin, and cotrimoxazole in a study in
Nigeria [3]. This study determined the signiﬁcance and the association of the strains of E. coli as a pre-
dominant isolates with diarrhea in children younger than 5 years in Cairo, Egypt. EPEC was identiﬁcation
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from fecal specimens to be considered as a unique pathogen or associated with other pathogens in acute
diarrheainchildren,topreventtheprolongedsequencesofdiarrhea.ThetrivalentE.coliantiserumisarapid
and easy test for laboratory screening for detection of EPEC. Also multi-drug-resistant enteropathogenic E.
coli can be associated with infantile diarrhea.
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